1501 related articles for article (PubMed ID: 32863955)
21. MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-
Hu J; Du H; Yuan Y; Guo P; Yang J; Yin X; Liu J; Wu S; Wan J; Gong X
Mediators Inflamm; 2022; 2022():5791915. PubMed ID: 35769208
[TBL] [Abstract][Full Text] [Related]
22. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
23. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
24. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
25. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
26. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress.
Lee GR; Lee HI; Kim N; Lee J; Kwon M; Kang YH; Song HJ; Yeo CY; Jeong W
J Cell Physiol; 2022 Sep; 237(9):3554-3564. PubMed ID: 35696549
[TBL] [Abstract][Full Text] [Related]
27. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
[TBL] [Abstract][Full Text] [Related]
29. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
30. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.
Zhang X; Shen J; Man K; Chu ES; Yau TO; Sung JC; Go MY; Deng J; Lu L; Wong VW; Sung JJ; Farrell G; Yu J
J Hepatol; 2014 Dec; 61(6):1365-75. PubMed ID: 25048951
[TBL] [Abstract][Full Text] [Related]
31. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
Li J; Sasaki GY; Dey P; Chitchumroonchokchai C; Labyk AN; McDonald JD; Kim JB; Bruno RS
J Nutr Biochem; 2018 Mar; 53():58-65. PubMed ID: 29190550
[TBL] [Abstract][Full Text] [Related]
32. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization.
Jiang K; Lu S; Li D; Liu M; Jin H; Lei B; Wang S; Long K; He S; Zhong F
J Gastroenterol; 2023 Sep; 58(9):894-907. PubMed ID: 37227481
[TBL] [Abstract][Full Text] [Related]
33. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
[TBL] [Abstract][Full Text] [Related]
34. Chronic high-fat diet induces galectin-3 and TLR4 to activate NLRP3 inflammasome in NASH.
Li H; Cao Z; Wang L; Li J; Cheng X; Tang Y; Xing M; Yao P
J Nutr Biochem; 2023 Feb; 112():109217. PubMed ID: 36402251
[TBL] [Abstract][Full Text] [Related]
35. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
36. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
[TBL] [Abstract][Full Text] [Related]
37. Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species.
Wang C; Zeng W; Wang L; Xiong X; Chen S; Huang Q; Zeng G; Huang Q
Drug Dev Res; 2024 Jun; 85(4):e22213. PubMed ID: 38798186
[TBL] [Abstract][Full Text] [Related]
38. SOCS2 Suppresses Inflammation and Apoptosis during NASH Progression through Limiting NF-κB Activation in Macrophages.
Li S; Han S; Jin K; Yu T; Chen H; Zhou X; Tan Z; Zhang G
Int J Biol Sci; 2021; 17(15):4165-4175. PubMed ID: 34803490
[No Abstract] [Full Text] [Related]
39. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
40. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]